1. Home
  2. NRXP vs AXIL Comparison

NRXP vs AXIL Comparison

Compare NRXP & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • AXIL
  • Stock Information
  • Founded
  • NRXP 2015
  • AXIL 2015
  • Country
  • NRXP United States
  • AXIL United States
  • Employees
  • NRXP N/A
  • AXIL N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • AXIL Package Goods/Cosmetics
  • Sector
  • NRXP Health Care
  • AXIL Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • AXIL Nasdaq
  • Market Cap
  • NRXP 32.6M
  • AXIL 36.5M
  • IPO Year
  • NRXP N/A
  • AXIL N/A
  • Fundamental
  • Price
  • NRXP $3.24
  • AXIL $5.02
  • Analyst Decision
  • NRXP Strong Buy
  • AXIL
  • Analyst Count
  • NRXP 4
  • AXIL 0
  • Target Price
  • NRXP $28.50
  • AXIL N/A
  • AVG Volume (30 Days)
  • NRXP 212.8K
  • AXIL 12.9K
  • Earning Date
  • NRXP 08-13-2025
  • AXIL 08-14-2025
  • Dividend Yield
  • NRXP N/A
  • AXIL N/A
  • EPS Growth
  • NRXP N/A
  • AXIL 93.65
  • EPS
  • NRXP N/A
  • AXIL 0.29
  • Revenue
  • NRXP N/A
  • AXIL $27,007,463.00
  • Revenue This Year
  • NRXP N/A
  • AXIL N/A
  • Revenue Next Year
  • NRXP N/A
  • AXIL N/A
  • P/E Ratio
  • NRXP N/A
  • AXIL $17.41
  • Revenue Growth
  • NRXP N/A
  • AXIL N/A
  • 52 Week Low
  • NRXP $1.10
  • AXIL $3.54
  • 52 Week High
  • NRXP $6.01
  • AXIL $10.75
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.62
  • AXIL 40.20
  • Support Level
  • NRXP $2.90
  • AXIL $4.84
  • Resistance Level
  • NRXP $3.53
  • AXIL $5.30
  • Average True Range (ATR)
  • NRXP 0.20
  • AXIL 0.40
  • MACD
  • NRXP -0.04
  • AXIL -0.01
  • Stochastic Oscillator
  • NRXP 58.73
  • AXIL 21.84

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About AXIL AXIL Brands Inc. Common Stock

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.

Share on Social Networks: